The essential symptoms of acute bronchitis are cough and expectoration of sputum that have lasted less than 3 weeks. In addition, there are usually other symptoms of respiratory tract infection (rhinitis, sore throat, hoarseness).
Acute bronchitis is usually a viral infection that does not require antimicrobial therapy.
The most important issue in the diagnostics is to exclude pneumonia.
Aetiology
The causative pathogens vary according to the epidemiological situation. The most common causative agents include coronaviruses, rhinoviruses, respiratory syncytial (RS) viruses, adenoviruses, parainfluenza and influenza viruses.
An aetiological diagnosis cannot be made based on symptoms and clinical findings.
Symptoms
Symptoms of acute bronchitis include:
cough
often purulent sputum
dyspnoea
wheezing
thoracic pain
fever rather rarely (10-30% of patients present with fever).
The duration of cough is about 2 weeks in most patients.
Acute bronchitis is usually associated with an infection in the upper respiratory tract and therefore the patient simultaneously has rhinitis, sore throat and hoarseness.
General symptoms are common: headache and debilitation occur in half of patients, muscle pain in one in four.
Diagnosis is based on patient history, clinical examination and follow-up of the further course.
Microbiological tests are of no benefit, except when influenza is suspected in cases where its drug treatment would be indicated.
It is essential to identify the patients in whom pneumonia should be suspected (see Differential diagnosis).
In a generally healthy person without significant general symptoms (heart rate < 100/min, respiratory rate < 20/min, body temperature < 38°C) and without pneumonic rales on auscultation or dullness to percussion, the probability of pneumonia is very small.
Differential diagnosis
The most important differential diagnosis to consider is pneumonia Pneumonia. It is significantly less common than bronchitis.
The differential diagnosis cannot be based on clinical symptoms and laboratory findings alone. Bronchitis and pneumonia are often caused by the same microbes - these diagnoses constitute differences in severity of the same disease.
In bronchitis the infection is limited to the mucous membranes of the bronchial tree while pneumonia represents an inflammation of the lung parenchyma, and its symptoms are therefore more severe.
Pneumonia
Pneumonia may be suspected if the patient has the following symptoms:
increased respiratory rate > 20/min
tachycardia (> 100/min)
abnormal findings in the respiratory exam
decreased breath sounds
dullness to percussion
rales
vocal resonance over a larger area than normal
oxygen saturation < 92% in room air.
If pneumonia is suspected, plain x-ray of the chest should be performed.
Taking a chest x-ray is further recommended in patients
with impaired general condition
with a prolonged or unusual course of the disease
with a primary disease, e.g. COPD, bronchiectasis, diabetes, or chronic cardiac, hepatic or renal disease predisposing them to pneumonia
with a history of pneumonia within the past year.
CRP > 100 mg/l strongly suggests pneumonia. If the CRP is < 20 mg/l and there are no symptoms or signs fitting pneumonia, pneumonia is unlikely.
In patients with severe symptoms, low CRP concentration does not exclude the possibility of a serious bacterial disease. CRP measurement is not reliable in the differential diagnostics if the symptoms have lasted less than 24 h.
Other differential diagnoses
The possibility of sinusitis Acute Maxillary Sinusitis should be excluded by ultrasound examination or x-ray in patients with persisting symptoms or local signs of sinusitis. Cough is a common symptom also in common cold, asthma and COPD.
The following conditions that sometimes resemble bronchitis should be borne in mind:
Honey, eucalyptus oil or any liquid that moistens the pharynx or larynx may alleviate cough, particularly when it is associated with an upper respiratory infection.
Of symptoms of upper respiratory tract infection, nasal congestion and mucus production can be alleviated by anticholinergics and sympathomimetics.
The benefit from sympathomimetics in the treatment of bronchitis is debatable Beta2-Agonists for Acute Bronchitis. Patients with obstruction associated with acute respiratory tract infection may benefit from sympathomimetics.
Because the course of the disease cannot be predicted from the clinical picture or the laboratory findings, regardless of whether or not antimicrobial therapy is performed, a patient with acute bronchitis must be given a new appointment if symptoms persist or become worse.